About Us

Mission Statement

Translating hematologic oncology advances into practice

Blood Cancers Today is a property that provides hematologists and oncologists with news, education, and information relevant to their patients and practices, with insight from experts in the field. As the online home of the publication, bloodcancerstoday.com is updated daily, with the most current information from around the specialty and multimedia content, including exclusive interviews with presenters at major medical meetings.

Blood Cancers Today was developed to reach all professionals in the hematology/oncology universe, covering the latest news and analysis in leukemia, lymphoma, myeloma, myeloproliferative neoplasms, and other hematologic malignancies.

The publication is produced in partnership with the Society of Hematologic Oncology, whose mission is to expedite worldwide research and exchange through the exchange of scientific information. Through this partnership, Blood Cancers Today is positioned to bring readers news, education, and cutting-edge research from the world of hematologic malignancies to better care for their patients with these disorders.

Editorial Policy

Blood Cancers Today publishes original article and video content from reputable sources and key opinion leaders. Our editorial staff is required to provide correct sourcing for the articles they develop, and for all accompanying images to avoid copyright infringement; and just as importantly, as not to betray the trust of our readers.

Examples of original content posted on Blood Cancers Today include:

  • News articles. Our editors, with guidance from the experts on our Editorial Board, diligently perform daily searches of peer-reviewed medical journals to report on recent, relevant studies related to hematologic oncology.
  • CommentaryBlood Cancers Today publishes original commentary pieces, whether submitted or written by members of our Editorial Board, that opine on a relevant topic for our readership. The views and opinions expressed in these articles are solely those of the authors and do not necessarily reflect the official policy or position of SOHO or Mashup Media, LLC.
  • Video interviews. We record, edit, and publish original video content with experts in hematologic oncology, including roundtable discussions of malignant hematology topics or interviews with presenters at major medical meetings. Blood Cancers Today retains proprietary rights over these videos unless otherwise granting permission to a third-party entity. All interviewees should be aware that Blood Cancers Today retains the right to use this video content at our discretion, and enters into not non-binding, non-legal understanding that certain sponsored videos may take precedence in publishing expediency. However, all videos receive the highest level of care in editing, with an emphasis placed on posting each one in a timely, responsible manner.
  • Podcasting is an area where we plan to expand in the near future with original, engaging discussions with hematologic oncology experts. These podcasts will cover a variety of meaningful topics and will adhere to the same standards of editorial integrity and excellence as our other content.

Licensed and Third-Party Content

Part of our mission to uphold the highest level of editorial integrity is to honor the rights of third-party content, defined in this context as any content that has not been developed by Blood Cancers Today. Our editorial staff often oversees the inclusion of such third-party content, which may include, but are not limited to:

  • Internet images
  • Screenshots
  • Tweets
  • Diagrams
  • Charts
  • Logos/Trademarks
  • Quotes
  • Interviews

Our policy directs that our editors provide either proper attribution for any third-party sources, and/or obtain written permission from the copyright owner, excluding image retrieval from paid subscription sites (such as Getty Images) and sites that house images considered to be in the public domain (such as Google Images).

When attributing information, Blood Cancers Today requires that our editors and contributors:

  • Disclose any conflicts of interest.
  • Verify the validity of all the sources when using information from social media.
  • Include where possible a source’s business, professional, and personal affiliations.
  • Attribute news to reputable, third-party sources, when necessary, through direct mention, preferably, or at the very least through linking to the original source.
  • Clearly state a source/opinion leader’s qualifications for speaking on the topic at hand.

Corrections Policy

The Blood Cancers Today editorial staff strives to present all information accurately, though, when human error occurs, we encourage our readers/sponsors to reach out, so that we might rectify them expeditiously. That process is as follows:

  • The authoring editor is notified of a factual error in a story or video and will redress that error forthwith via our content management system, or if, needed, through collaboration with our digital team.
  • Once said correction is made, the editor is responsible for adding text the bottom of the content piece to clarify what alterations/changes have been made.
  • The article date is only changed if the story has required marked changes or undergone internal medical review.
  • The party who pinpointed the error/s is notified of the change and provided a URL of the updated content piece.

Additionally, our editorial staff is required to never, under any circumstances, intentionally misrepresent facts, or otherwise write in bad faith or exhibit clear biases. We reaffirm our stance as impartial arbiters of truth, and balance in medical reporting.

Advertisement
Advertisement